4.7 Article

Negative regulation of transcription by the type II arginine methyltransferase PRMT5

期刊

EMBO REPORTS
卷 3, 期 7, 页码 641-645

出版社

NATURE PUBLISHING GROUP
DOI: 10.1093/embo-reports/kvf136

关键词

-

资金

  1. NCI NIH HHS [R01-CA46465, R01 CA046465] Funding Source: Medline
  2. NIAID NIH HHS [R01-AI43369, R01 AI36450, R01 AI036450, R01 AI043369, 2T32AI07403, T32 AI007403] Funding Source: Medline

向作者/读者索取更多资源

We have identified previously a repressor element in the transcription start site region of the cyclin E1 promoter that periodically associates with an atypical, high molecular weight E2F complex, termed CERC. Purification of native CERC reveals the presence of the type II arginine methyltransferase PRMT5, which can mono- or symetrically dimethylate arginine residues in proteins. Chromatin immunoprecipitations (ChIPs) show that PRMT5 is associated specifically with the transcription start site region of the cyclin El promoter. ChIP analyses also show that this correlates with the presence on the same promoter region of arginine-methylated proteins including histone H4, an in vitro substrate of PRMT5. Consistent with its presence within the repressor complex, forced expression of PRMT5 negatively affects cyclin E1 promoter activity and cellular proliferation, effects that require its methyltransferase activity. These data provide the first direct experimental evidence that a type II arginine methylase is involved in the control of transcription and proliferation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据